| 今开：12.42 | 昨收：12.27 |
| 最高：12.82 | 最低：12.16 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：4.68237969E8 |
Nevro(NVRO)02-24 06:45
$Nevro(NVRO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-019464 Act: 34 Size: 18 MB 网页链接查看全文
Nevro(NVRO)03-02 07:05
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000104 Size: 4 KB 网页链接查看全文
Nevro(NVRO)03-02 07:05
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000105 Size: 4 KB 网页链接查看全文
Nevro(NVRO)03-06 05:25
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000125 Size: 4 KB 网页链接查看全文
Nevro(NVRO)03-06 05:25
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000126 Size: 4 KB 网页链接查看全文
Nevro(NVRO)03-07 07:55
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000138 Size: 6 KB 网页链接查看全文
Nevro(NVRO)03-07 07:55
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000137 Size: 6 KB 网页链接查看全文
Nevro(NVRO)03-12 04:55
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000147 Size: 6 KB 网页链接查看全文
Nevro(NVRO)03-12 04:55
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000144 Size: 6 KB 网页链接查看全文
Nevro(NVRO)04-13 04:55
$Nevro(NVRO)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-044100 Act: 34 Size: 6 MB 网页链接查看全文
夹头博士DrChuck2023-07-29 21:35
回复@陈达美股投资: 相当专业，$Nevro(NVRO)$ 不幸的落入了苟延残喘的境地，不过21年大放水时也超过了霸道总裁的情节。估值确实是科学和艺术的结合，严谨分析财报和模型的科学家总被疯狂的市场艺术家调戏～//@陈达美股投资:回复@Hello朱:我知乎上那篇巨长的手把手教你DCF，有网友反映被大学corpora...查看全文
蹊之美股生物医药2021-08-06 22:10
作者：林出
微信公众号：蹊之美股生物医药 / CaesarBiotech
Gainers:
Profound Medical (NASDAQ:PROF) +29%
STAAR Surgical (NASDAQ:STAA) +20%
AdaptHealth (NASDAQ:AHCO) +15%
Flora Growth (NASDAQ:FLGC) +12%
Invacare (NYSE:IVC) +14%
L...查看全文
郁闷的鞋套-2021-07-20 12:42
$Nevro(NVRO)$ 2021年7月19日，Nevro公司宣布，其专有的10 kHZ脊髓刺激（SCS）“Senza”系统，已获得美国FDA批准，用于治疗疼痛性糖尿病神经病变（PDN）引起的慢性疼痛。新闻稿指出，这是FDA批准的首款以PDN为适应症的脊髓刺激系统。该公司将根据本次批准，推出的名为“HFX”的PDN治疗相关产品。HF...查看全文
智通财经APP获悉，鉴于多数大型医疗科技公司已公开表示有意在该领域进行收购，摩根大通分析师Robbie Marcus列出了潜在的收购目标，包括：英特格拉生命科学(IART.US)、Nevro (NVRO.US)、纽瓦索器材(NUVA.US)、Silk Road Medical (SILK.US... 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-20-011144 Size: 6 KB 网页链接
$Nevro(NVRO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-20-021316 Act: 34 Size: 9 MB 网页链接
$Nevro(NVRO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-20-021273 Act: 34 Size: 451 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-20-007937 Size: 4 KB 网页链接
$Nevro(NVRO)$ 8-K Current report, item 8.01 Accession Number: 0001564590-20-016314 Act: 34 Size: 157 KB 网页链接
$Nevro(NVRO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001564590-20-016130 Act: 34 Size: 222 KB 网页链接
$Nevro(NVRO)$ DEF 14A Other definitive proxy statements Accession Number: 0001564590-20-016121 Act: 34 Size: 1 MB 网页链接
$Nevro(NVRO)$ 8-K Current report, items 1.01, 2.03, 3.02, and 9.01 Accession Number: 0001193125-20-099922 Act: 34 Size: 3 MB 网页链接
$Nevro(NVRO)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-20-098460 Act: 34 Size: 74 KB 网页链接
$Nevro(NVRO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-20-098454 Act: 33 Size: 853 KB 网页链接